Skip to main content

Advertisement

Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review

Article metrics

The original article was published in Orphanet Journal of Rare Diseases 2018 13:47

Correction to: Orphanet J Rare Dis

https://doi.org/10.1186/s13023-018-0795-5

After publication of this article [1], it is noticed reference no. 17 was incorrectly provided, details are shown below:

Original reference no. 17:

Canalis E, Schilling L, Yee SP, Lee SK, Zanotti S. Hajdu Cheney mouse mutants exhibit osteopenia, increased Osteoclastogenesis, and bone resorption. J Biol Chem. 2016;291(4):1538–51. https://doi.org/10.1074/jbc. M115.685453.

Correct reference no. 17:

G. Adami, M. Rossini, D. Gatti, G. Orsolini, L. Idolazzi, O. Viapiana, A. Scarpa, E. Canalis Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab Bone, 92 (2016), pp. 150–156.

The author apologizes for the inconvenience caused.

Reference

  1. 1.

    Pittaway, et al. Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review. Orphanet J Rare Dis. 2018;13:47 https://doi.org/10.1186/s13023-018-0795-5.

Download references

Author information

Correspondence to James F. H. Pittaway.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark